Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England

PURPOSE: Treatment pathways of patients with chronic obstructive pulmonary disease (COPD) receiving single-inhaler dual therapies remain unclear. We aimed to describe characteristics, prescribed treatments, healthcare resource use (HCRU) and costs of patients with COPD who initiated single-inhaler l...

Descripción completa

Detalles Bibliográficos
Autores principales: Requena, Gema, Banks, Victoria, Czira, Alexandrosz, Wood, Robert, Tritton, Theo, Wild, Rosie, Compton, Chris, Duarte, Maria, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379125/
https://www.ncbi.nlm.nih.gov/pubmed/35983168
http://dx.doi.org/10.2147/COPD.S365480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379125/
https://www.ncbi.nlm.nih.gov/pubmed/35983168
http://dx.doi.org/10.2147/COPD.S365480

Ejemplares similares